Cargando…

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States

Cervical cancer is widely preventable through screening, but little is known about the duration of protection offered by a negative screen in North America. A case–control study was conducted with records from population‐based registries in New Mexico. Cases were women diagnosed with cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landy, Rebecca, Sasieni, Peter D., Mathews, Christopher, Wiggins, Charles L., Robertson, Michael, McDonald, Yolanda J., Goldberg, Daniel W., Scarinci, Isabel C., Cuzick, Jack, Wheeler, Cosette M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282928/ https://www.ncbi.nlm.nih.gov/pubmed/31837006 http://dx.doi.org/10.1002/ijc.32826

Ejemplares similares

A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States
por: Landy, Rebecca, et al.
Publicado: (2020)

Erratum to ‘A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States’ [Gynecologic Oncology 159 (2020) 344–353]
por: Landy, Rebecca, et al.
Publicado: (2021)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

DNA methylation testing with S5 for triage of high‐risk HPV positive women
por: Adcock, Rachael, et al.
Publicado: (2022)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

Cancer incidence in the United Kingdom: projections to the year 2030
por: Mistry, M, et al.
Publicado: (2011)

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
por: Del Mistro, Annarosa, et al.
Publicado: (2018)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016
por: Orumaa, Madleen, et al.
Publicado: (2019)

Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
por: Ring, Linea Landgrebe, et al.
Publicado: (2022)

Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations
por: Perkins, Rebecca B., et al.
Publicado: (2021)

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends
por: Vélez, Ramón, et al.
Publicado: (2016)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis
por: Campos, Nicole G., et al.
Publicado: (2018)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
por: Brentnall, Adam R., et al.
Publicado: (2019)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
por: Kahesa, Crispin, et al.
Publicado: (2022)

Cancer incidence in English children, adolescents and young people: past trends and projections to 2030
por: Pesola, Francesca, et al.
Publicado: (2017)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing
por: Andreassen, Trude, et al.
Publicado: (2019)

Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study
por: McBride, Emily, et al.
Publicado: (2019)

Cancer mortality in the United Kingdom: projections to the year 2025
por: Olsen, A H, et al.
Publicado: (2008)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low‐resource settings
por: Campos, Nicole G., et al.
Publicado: (2017)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Incidence and mortality trends of melanoma in Croatia, 1988-2008
por: Barbarić, Jelena, et al.
Publicado: (2012)

Trends in prostate cancer incidence and mortality in Croatia, 1988 to 2008
por: Kuliš, Tomislav, et al.
Publicado: (2012)

Trends in lung cancer incidence and mortality in Croatia, 1988 to 2008
por: Janković, Mateja, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_266ienph1390c4d6r01u769ud9